Experiences with a sac-type artificial heart

Area of Science:

• Biomedical Engineering
• Cardiovascular Research
• Medical Device Development

Background:

• The limitations of current treatments for end-stage heart failure necessitate advanced solutions.
• Total artificial hearts (TAHs) offer a potential alternative to heart transplantation.
• Developing a TAH with sustained in vivo functionality remains a significant challenge.

Purpose of the Study:

• To describe the design and initial in vitro and in vivo performance of a total replacement artificial heart.
• To assess the feasibility of implanting the artificial heart in experimental animals.
• To identify preliminary challenges and areas for improvement in the TAH system.

Main Methods:

• In vitro testing to evaluate performance against human physiological requirements.
• Surgical implantation of the TAH into experimental animal models.
• In vivo monitoring of hemodynamic parameters (blood flow and pressure) for up to six hours.
• Preliminary analysis of biocompatibility issues, including air embolism and hemolysis.

Main Results:

• The artificial heart demonstrated in vitro performance suitable for moderate activity levels.
• Successful in vivo implantation and adequate blood flow and pressure provision were achieved in experimental animals for up to six hours.
• Preliminary testing identified significant issues with air embolism and red blood cell hemolysis.

Conclusions:

• The developed total replacement artificial heart shows promise for supporting physiological needs.
• Further design modifications and implantation technique refinements are necessary to address identified biocompatibility issues.
• Larger animal studies are required for comprehensive evaluation of the TAH's long-term potential and safety.